Fig. 3From: Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trialDisease-free survival (a) and overall survival curves (b) of the TME and CCRT + TME groups. TME, total mesorectal excision; CCRT, concurrent chemoradiotherapy; HR, hazard ratio; CI, confidence intervalBack to article page